Package 57970-100-01

Brand: dalvance

Generic: dalbavancin
NDC Package

Package Facts

Identity

Package NDC 57970-100-01
Digits Only 5797010001
Product NDC 57970-100
Product ID 57970-100_c8fc5d09-57d1-4c85-aa4d-6bde6a25dcab
Description

1 VIAL in 1 PACKAGE (57970-100-01) / 25 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2014-05-23
Brand dalvance
Generic dalbavancin
Sample Package No

Linked Drug Pages (1)

DALVANCE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "c8fc5d09-57d1-4c85-aa4d-6bde6a25dcab", "openfda": {"unii": ["33WDQ7T81E"], "rxcui": ["1539243", "1539248"], "spl_set_id": ["4b4674d8-4d1e-4728-8465-d42ada33fa5c"], "manufacturer_name": ["Allergan, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 PACKAGE (57970-100-01)  / 25 mL in 1 VIAL", "package_ndc": "57970-100-01", "marketing_start_date": "20140523"}], "brand_name": "DALVANCE", "product_id": "57970-100_c8fc5d09-57d1-4c85-aa4d-6bde6a25dcab", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Lipoglycopeptide Antibacterial [EPC]", "Lipoglycopeptides [CS]"], "product_ndc": "57970-100", "generic_name": "Dalbavancin", "labeler_name": "Allergan, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DALVANCE", "active_ingredients": [{"name": "DALBAVANCIN HYDROCHLORIDE", "strength": "500 mg/25mL"}], "application_number": "NDA021883", "marketing_category": "NDA", "marketing_start_date": "20140523", "listing_expiration_date": "20261231"}